tanshinone has been researched along with Nephritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, K; Duan, JA; Liu, F; Su, SL; Xu, Z; Zhu, Y | 1 |
| Ding, Y; Han, S; He, L; Liu, J; Ren, X; Wang, L; Yao, C; Zhai, W; Zhang, X | 1 |
1 trial(s) available for tanshinone and Nephritis
| Article | Year |
|---|---|
Traditional Chinese medicine versus regular therapy in Henoch-Schönlein purpura nephritis in children: study protocol for a randomized controlled trial.
Topics: Abietanes; Adolescent; Age Factors; Child; Child, Preschool; China; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Glycosides; Humans; IgA Vasculitis; Male; Multicenter Studies as Topic; Nephritis; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Tripterygium | 2019 |
1 other study(ies) available for tanshinone and Nephritis
| Article | Year |
|---|---|
Salvianolic acid B and tanshinone IIA synergistically improve early diabetic nephropathy through regulating PI3K/Akt/NF-κB signaling pathway.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Glucose; Inflammation; Nephritis; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2024 |